Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the ...
Beam Therapeutics (NasdaqGS:BEAM) launched BEAM-304, a new base-editing genetic medicine program for phenylketonuria, expanding its liver-targeted portfolio. The company entered a $500 million ...
Million Funded at Close with up to an Additional $400 Million Available Under Facility with Seven-Year TermFinancing Bolsters Balance Sheet ...
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the top gene therapy stocks to buy according to hedge funds. On February 25, ...
Beam Therapeutics BEAM shares are rising Tuesday after the company reported quarterly results. Beam Therapeutics stock is surging to new heights today. What’s fueling BEAM momentum? Beam Surpasses ...
Add Yahoo as a preferred source to see more of our stories on Google. (Photo: Jim Beam) Jim Beam is bringing back a postseason promotion aimed at football fans whose teams did not make a championship ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results